DK0443996T3 - Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma - Google Patents

Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma

Info

Publication number: DK0443996T3
Authority: DK; Denmark
Prior art keywords: acid; carnitines; carnitine; coma; beta
Prior art date: 1990-02-23

Application number

DK91830062.5T

Other languages

English (en)

Inventor

Domenico Misiti

Maria Ornella Tinti

Nazareno Scafetta

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-23

Filing date

1991-02-21

Publication date

1994-07-25

1991-02-21 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

1994-07-25 Application granted granted Critical

1994-07-25 Publication of DK0443996T3 publication Critical patent/DK0443996T3/da

Links

-1 acyl (R) (-) - carnitines Chemical class 0.000 title abstract 5
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
206010010071 Coma Diseases 0.000 title abstract 2
150000002148 esters Chemical class 0.000 title abstract 2
210000004185 liver Anatomy 0.000 title abstract 2
230000004770 neurodegeneration Effects 0.000 title abstract 2
230000017854 proteolysis Effects 0.000 title abstract 2
WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 title 2
230000005764 inhibitory process Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000002253 acid Substances 0.000 abstract 8
150000003839 salts Chemical class 0.000 abstract 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
206010039966 Senile dementia Diseases 0.000 abstract 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
229940009098 aspartate Drugs 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 abstract 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK91830062.5T 1990-02-23 1991-02-21 Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma DK0443996T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT47669A IT1240775B (it)	1990-02-23	1990-02-23	Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Publications (1)

Publication Number	Publication Date
DK0443996T3 true DK0443996T3 (da)	1994-07-25

Family

ID=11261785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91830062.5T DK0443996T3 (da)	1990-02-23	1991-02-21	Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma

Country Status (8)

Country	Link
EP (1)	EP0443996B1 (da)
JP (1)	JP2930755B2 (da)
AT (1)	ATE107624T1 (da)
DE (1)	DE69102560T2 (da)
DK (1)	DK0443996T3 (da)
ES (1)	ES2056620T3 (da)
HK (1)	HK1005868A1 (da)
IT (1)	IT1240775B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1248321B (it) *	1991-05-15	1995-01-05	Sigma Tau Ind Farmaceuti	Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
IT1254135B (it) *	1992-01-16	1995-09-08	Sigma Tau Ind Farmaceuti	Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica.
IT1254136B (it) *	1992-01-16	1995-09-08	Sigma Tau Ind Farmaceuti	Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.
IT1263013B (it) *	1992-10-20	1996-07-23	Avantgarde Spa	Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261984B (it) *	1993-06-22	1996-06-11	Avantgarde Spa	Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
AU6513298A (en) *	1997-03-17	1998-10-12	British Technology Group Limited	Therapeutic compositions
US6323237B1 (en)	1997-03-17	2001-11-27	Btg International Limited	Therapeutic compositions
US6835750B1 (en)	2000-05-01	2004-12-28	Accera, Inc.	Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
WO2001082928A1 (en) *	2000-05-01	2001-11-08	Accera, Inc.	Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
PT2001293T (pt)	2006-04-03	2018-11-28	Accera Inc	Utilização de compostos cetogénicos para tratamento de comprometimento da memória associado à idade
CN1995010B (zh) *	2006-12-29	2012-12-12	辽宁科硕营养科技有限公司	一种合成丙酰左旋肉碱盐酸盐的方法
ES2608286T3 (es)	2007-07-31	2017-04-07	Accera, Inc.	Uso de ensayos genómicos y compuestos cetogénicos para tratamiento de una función cognitiva reducida
KR101734152B1 (ko)	2008-07-03	2017-05-11	액세라인크	신경계 장애의 치료를 위한 아세토아세테이트의 모노글리세리드 및 유도체
CN112341331B (zh) *	2019-08-07	2023-04-07	辽宁科硕营养科技股份有限公司	一种3-羟基丁酸盐及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1116037B (it) *	1979-04-23	1986-02-10	Sigma Tau Ind Farmaceuti	Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145362B (it) *	1980-03-06	1986-11-05	Sigma Tau Ind Farmaceuti	Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT1209564B (it) *	1984-06-29	1989-08-30	Magis Farmaceutici	Derivati della l-carnitina o di l-acil carnitina.

1990
- 1990-02-23 IT IT47669A patent/IT1240775B/it active IP Right Grant
1991
- 1991-02-21 EP EP91830062A patent/EP0443996B1/en not_active Expired - Lifetime
- 1991-02-21 ES ES91830062T patent/ES2056620T3/es not_active Expired - Lifetime
- 1991-02-21 DE DE69102560T patent/DE69102560T2/de not_active Expired - Fee Related
- 1991-02-21 AT AT91830062T patent/ATE107624T1/de not_active IP Right Cessation
- 1991-02-21 DK DK91830062.5T patent/DK0443996T3/da active
- 1991-02-22 JP JP3050644A patent/JP2930755B2/ja not_active Expired - Fee Related
1998
- 1998-06-05 HK HK98104950A patent/HK1005868A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69102560T2 (de)	1994-10-13
JP2930755B2 (ja)	1999-08-03
ES2056620T3 (es)	1994-10-01
IT1240775B (it)	1993-12-17
JPH0597785A (ja)	1993-04-20
IT9047669A1 (it)	1991-08-24
EP0443996B1 (en)	1994-06-22
DE69102560D1 (de)	1994-07-28
EP0443996A1 (en)	1991-08-28
IT9047669A0 (it)	1990-02-23
ATE107624T1 (de)	1994-07-15
HK1005868A1 (en)	1999-01-29

Publication	Publication Date	Title
DK0442850T3 (da)	1994-09-05	Estere af acyl L-carnitiner med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende disse til hæmning af neurondegeneration og til behandling af coma
DK0443996T3 (da)	1994-07-25	Estere af (R)(-)-carnitin og acyl (R)(-)-carnitiner med beta-hydroxysmørsyre og farmaceutiske præparater indeholdende disse til inhibering af neurondegeneration og leverproteolyse samt til behandling af coma
DK0429403T3 (da)	1994-08-01	Ester af L-carnitin med gamma-hydroxysmørsyre samt farmaceutiske præparater indeholdende denne til inhibering af neurondegeneration og til behandling af coma
CA1252098A (en)	1989-04-04	Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
HUT61001A (en)	1992-11-30	Process for producing phenylpyrazolidinone derivatives and pharmaceutical compositions comprising such compounds
EP0290819A3 (en)	1990-10-10	Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity
DK0514359T3 (da)	1995-11-13	Alkanoyl-L-carnitin-amider med aminosyrer og farmaceutiske præparater indeholdende disse til fremme af regeneration af nervevæv, inhibering af neuronal degeneration, forøgelse af indlærings- og hukommelsesprocesserne og behandling af coma
ATE132746T1 (de)	1996-01-15	Verwendung der ester von acyl-l-carnitin mit gamma-hydroxy-buttersäure zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von lebererkrankungen
AU7624494A (en)	1995-04-03	Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
KR940006576A (ko)	1994-04-25	에이즈 및 에이즈 관련 증후군 환자 및 무증후성 hiv혈청양성 환자치료를 위한 l-카르니틴 및 아실 l-카르니틴의 용도
IE882538L (en)	1989-02-21	Oximes of tetrahydropyridine-3-carboxaldehyde
GR3018184T3 (en)	1996-02-29	3-(1,2-Benzisoxazol-3-yl)-4-pyridinamines and derivatives.
HU895648D0 (en)	1990-01-28	Process for the preparation of n,n-disubstituted diaryl-alkancarboxylic acid amide derivatives and pharmaceutical compositions containing such compounds
EP0177574B1 (en)	1989-12-20	Aminocarnitines
ATE167056T1 (de)	1998-06-15	Verwendung von ester von acyl-l-carnitin mit gammahydroxybuttersäure zur behandlung von alkoholismus
NO961540D0 (no)	1996-04-18	Fremgangsmåte for fremstilling av metandifosfonsyre-forbindelser
NZ616467A (en)	2015-10-30	Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease